StockData

Aspira Women's Health Inc. (AWHL) stock

AWHLOTCIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 1/30
$0.22−0.01 (-2.61%)

Close on Oct 19, 2026Market cap $9.91MP/E –Yield –

Aspira Women's Health profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Aspira Women's Health's profit margin for the twelve months ending Jun 30, 2026 was -5885.3%. For fiscal 2025 it was -3725.9%, against -327350.0% the year before. The highest annual figure on record is -19.2% in fiscal 2023.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-3725.9%+323624.1
FY2024Dec 31, 2024-327350.0%−327330.8
FY2023Dec 31, 2023-19.2%+346.0
FY2022Dec 31, 2022-365.2%+99.6
FY2021Dec 31, 2021-464.8%−79.8
FY2020Dec 31, 2020-385.0%−49.2
FY2019Dec 31, 2019-335.8%+36.7
FY2018Dec 31, 2018-372.5%−36.1
FY2017Dec 31, 2017-336.3%+230.2
FY2016Dec 31, 2016-566.5%+311.5
FY2015Dec 31, 2015-878.0%−116.1
FY2014Dec 31, 2014-762.0%−418.3
FY2013Dec 31, 2013-343.7%−2.4
FY2012Dec 31, 2012-341.3%+583.9
FY2011Dec 31, 2011-925.1%+694.8
FY2010Dec 31, 2010-1619.9%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 2026-14235.3%−12657.8
Q1 FY2026Mar 31, 20262112.5%+2269.7
Q4 FY2025Dec 31, 2025-10528.1%−10382.4
Q3 FY2025Sep 30, 2025-5496.6%−5281.6
Q2 FY2025Jun 30, 2025-1577.5%−1573.7
Q3 FY2024Sep 30, 2024-157.2%+55.1
Q2 FY2024Jun 30, 2024-145.7%−52.7
Q1 FY2024Mar 31, 2024-215.0%+69.0
Q4 FY2023Dec 31, 2023-3.9%+209.4
Q3 FY2023Sep 30, 2023-212.3%+163.4
Q2 FY2023Jun 30, 2023-93.0%+306.0
Q1 FY2023Mar 31, 2023-284.0%+205.6
Q4 FY2022Dec 31, 2022-213.2%+270.9
Q3 FY2022Sep 30, 2022-375.6%+207.0
Q2 FY2022Jun 30, 2022-399.0%−5.8
Q1 FY2022Mar 31, 2022-489.6%−93.9
Q4 FY2021Dec 31, 2021-484.1%−63.6
Q3 FY2021Sep 30, 2021-582.7%−236.6
Q2 FY2021Jun 30, 2021-393.2%+120.3
Q1 FY2021Mar 31, 2021-395.7%−92.0
Q4 FY2020Dec 31, 2020-420.5%−161.6
Q3 FY2020Sep 30, 2020-346.0%−48.7
Q2 FY2020Jun 30, 2020-513.5%−135.8
Q1 FY2020Mar 31, 2020-303.8%+159.0
Q4 FY2019Dec 31, 2019-258.9%+46.9
Q3 FY2019Sep 30, 2019-297.3%+45.4
Q2 FY2019Jun 30, 2019-377.8%+52.9
Q1 FY2019Mar 31, 2019-462.8%−23.6
Q4 FY2018Dec 31, 2018-305.9%+64.4
Q3 FY2018Sep 30, 2018-342.6%+16.3
Q2 FY2018Jun 30, 2018-430.6%−167.8
Q1 FY2018Mar 31, 2018-439.1%−71.0
Q4 FY2017Dec 31, 2017-370.3%−16.8
Q3 FY2017Sep 30, 2017-358.9%+199.0
Q2 FY2017Jun 30, 2017-262.8%–
Q1 FY2017Mar 31, 2017-368.2%–
Q4 FY2016Dec 31, 2016-353.5%–
Q3 FY2016Sep 30, 2016-557.9%–

More Aspira Women's Health figures

See a number that looks wrong?